HKSE:3613
Beijing Tong Ren Tang Chinese Medicine Company Limited · HKSE · Healthcare · HKD · FY for 2025
Figures on this page computed 2026-11-08 13:42 UTC
Last close
n/aHKD
Market data
12.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
18.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
26.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
54.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
6.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Growth is the furthest below its sector's middle: 0.25 against 0.47 on the market's range.
Follow one dollar
lens 1 of 9After what it costs to make
61.2%
After running the business
31.2%
After interest and tax
26.3%
After what it must reinvest
54.7%
Kept after the dividend
35.3%
The five stops
5 of 5 read- After what it costs to make925,576,00061.2%
- After running the business472,239,00031.2%
- After interest and tax397,216,00026.3%
- After what it must reinvest827,051,00054.7%
- Kept after the dividend534,066,00035.3%
Of every unit of sales, 0.35 is still there after the dividend.
Of every unit of sales, 0.35 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales1,513,357,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
After what it costs to make925,576,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
After running the business472,239,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
After interest and tax397,216,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
After what it must reinvest827,051,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
Kept after the dividend534,066,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD